Artiva Biotherapeutics (ARTV) Operating Expenses (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Operating Expenses of $24.4 million for Q1 2026, up 10.19% year-over-year from $22.2 million in Q1 2025, and up 11.39% quarter-over-quarter from $21.9 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Operating Expenses (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Operating Expenses for 4 consecutive years, with $24.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 10.19% year-over-year to $24.4 million; the TTM figure through Mar 2026 stood at $92.1 million (up 22.82% YoY), while the FY2025 annual figure was $89.8 million, up 32.99% from the prior year.
- Operating Expenses advanced to $24.4 million in Q1 2026 per ARTV's latest filing, from $21.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $24.4 million in Q1 2026 and bottomed at $14.3 million in Q4 2023.
- Historically, Operating Expenses has averaged $18.9 million across 4 years, with a median of $18.3 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Expenses advanced 5.67% — and 2025, when it jumped 50.38%.
- Artiva Biotherapeutics' Operating Expenses stood at $14.3 million in 2023, then gained by 27.56% to $18.3 million in 2024, then advanced by 20.06% to $21.9 million in 2025, then gained by 11.39% to $24.4 million in 2026.
- Business Quant data shows ARTV's Operating Expenses at $24.4 million in Q1 2026, $21.9 million in Q4 2025, and $22.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 26.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.89 Mn |
| Mar 31, 2026 | 24.43 Mn |
| Dec 31, 2025 | 21.93 Mn |
| Sep 30, 2025 | 22.90 Mn |
| Jun 30, 2025 | 22.81 Mn |
| Mar 31, 2025 | 22.17 Mn |
| Dec 31, 2024 | 18.27 Mn |
| Sep 30, 2024 | 18.34 Mn |
| Jun 30, 2024 | 16.19 Mn |
| Mar 31, 2024 | 14.74 Mn |
| Dec 31, 2023 | 14.32 Mn |
| Sep 30, 2023 | 15.85 Mn |
| Jun 30, 2023 | 15.32 Mn |